📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Biocrates

1.1 - Company Overview

Biocrates Logo

Biocrates

Headquarter: Austria
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of metabolomics platforms for biomarker discovery and validation in complex diseases. Offers the MxP Quant 500 XL kit for profiling >1,000 compounds, WebIDQ software, MetaboINDICATOR, and data interpretation and statistical analysis services, alongside automated sample preparation integrated with mass-spectrometric methods.

Products and services

  • MxP Quant 500 XL: Research-grade metabolomics kit delivering comprehensive metabolic profiling by quantifying over 1,000 compounds across various biochemical classes, enabling broad pathway coverage for biomarker discovery and validation
  • WebIDQ software: Modular software for processing and analyzing data from metabolomics kits, with built-in tools for data normalization and analysis to support consistent dataset handling
  • Data and interpretation services: Kit-agnostic service delivering comprehensive statistical analysis and data interpretation for metabolomics datasets, regardless of the kit used

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Biocrates

Rare Thyroid Therapeutics Logo

Rare Thyroid Therapeutics

HQ: Sweden Website
  • Description: Provider of late-stage orphan drug development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rare Thyroid Therapeutics company profile →
Millendo Therapeutics Logo

Millendo Therapeutics

HQ: United States Website
  • Description: Provider of biopharmaceutical research and development, previously primarily focused on developing novel treatments for endocrine diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Millendo Therapeutics company profile →
OrsoBio Logo

OrsoBio

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical therapies for severe metabolic disorders, including TLC-3595 (selective ACC2 inhibitor) to improve insulin sensitivity in type 2 diabetes; TLC-2716 (liver-targeted LXR inverse agonist) to lower plasma triglycerides and cholesterol in severe dyslipidemias; mitochondrial protonophores (TLC-6740, TLC-1235) to increase energy expenditure; and an ACMSD inhibitor to augment NAD+ and mitochondrial function in liver/kidney dysfunction.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full OrsoBio company profile →
PhaseBio Logo

PhaseBio

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical drug development targeting cardiovascular, endocrine, and metabolic disorders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full PhaseBio company profile →
Standard Bariatrics Logo

Standard Bariatrics

HQ: United States Website
  • Description: Provider of surgical instruments for weight-loss surgeries, focused on sleeve gastrectomy. Offerings include Titan SGS, a surgical stapler with a 23 cm continuous staple line for consistent sleeve anatomy; Standard Precision Bougie Device for precise alignment and protection of the incisura angularis; Standard Trocar, a bladeless access device for introducing Titan SGS; and Standard Clamp to plan and hold the staple line, helping standardize technique and improve efficiency.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Standard Bariatrics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Biocrates

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Biocrates

2.2 - Growth funds investing in similar companies to Biocrates

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Biocrates

4.2 - Public trading comparable groups for Biocrates

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Biocrates

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Biocrates

What does Biocrates do?

Biocrates is a provider of metabolomics platforms for biomarker discovery and validation in complex diseases. Offers the MxP Quant 500 XL kit for profiling >1,000 compounds, WebIDQ software, MetaboINDICATOR, and data interpretation and statistical analysis services, alongside automated sample preparation integrated with mass-spectrometric methods.

Who are Biocrates's competitors?

Biocrates's competitors and similar companies include Rare Thyroid Therapeutics, Millendo Therapeutics, OrsoBio, PhaseBio, and Standard Bariatrics.

Where is Biocrates headquartered?

Biocrates is headquartered in Austria.

How many employees does Biocrates have?

Biocrates has 1,000 employees 🔒.

When was Biocrates founded?

Biocrates was founded in 2010 🔒.

What sector and industry vertical is Biocrates in?

Biocrates is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Biocrates

Who are the top strategic acquirers in Biocrates's sector and industry

Top strategic M&A buyers and acquirers in Biocrates's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Biocrates?

Top strategic M&A buyers groups and sectors for Biocrates include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Biocrates's sector and industry vertical

Which are the top PE firms investing in Biocrates's sector and industry vertical?

Top PE firms investing in Biocrates's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Biocrates's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Biocrates's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Biocrates's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Biocrates include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Biocrates's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Biocrates?

The key public trading comparables and valuation benchmarks for Biocrates include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Biocrates for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Biocrates with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Biocrates's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Biocrates with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Biocrates's' sector and industry vertical?

Access recent funding rounds and capital raises in Biocrates's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Biocrates